Canaccord Genuity将Hims & Hers Health的目标价从32美元上调至40美元，维持“买入”评级。(格隆汇)
GE Gelonghui Canaccord Genuity上调Hims & Hers Health目标价至40美元 2026/7/3 GMT+8 11:02 Gelonghui HI HIMS Canaccord Genuity将Hims & Hers Health的目标价从32美元上调至40美元，维持“买入”评级。(格隆汇) 市场新闻 Gelonghui Canaccord Genuity上调Hims & Hers Health目标价至40美元 Reuters 陶氏、Palo Alto Networks、Zions Bancorporation Reuters 陶氏、Palo Alto Networks、Zions Bancorporation Reuters 陶氏、Palo Alto Networks、Zions Bancorporation
